GLP-1
+3
Jul 28, 2026
•
7 min read
Retatrutide revolution continues
Weight loss remains the star of the show, but cardiovascular data was underpowered
GLP-1
+1
Jul 16, 2026
•
10 min read
What is the deal with liver concerns in small molecule GLP-1s?
A guest post by Jen Can NuSH on liver concerns and small molecule GLP1 medications
GLP-1
+3
Jul 2, 2026
•
14 min read
ADA Conference 2026: Zenagamtide, Berobenatide, UBT251, enicepatide & orforglipron
Orals, Triples, Biologics and even more data from ADA 2026
